Breaking News: Embargoed Feed - hidden

Filters close
Query Closed
Reporter's Deadline Passed
17-Jan-2024 11:43 AM EST
Hello, I am looking for - Rebecca Sohn, Space.com
Newswise Expert Queries

Hello, I am looking for a physicist to help me answer a hypothetical question for

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 1:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 1:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Jan-2024 5:00 PM EST Released to reporters: 23-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 29-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:  New technology makes cancer easier for immune system to find and destroy
26-Jan-2024 7:00 AM EST
New technology makes cancer easier for immune system to find and destroy
Hokkaido University

A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.

Newswise:  New technology makes cancer easier for immune system to find and destroy
26-Jan-2024 7:00 AM EST
New technology makes cancer easier for immune system to find and destroy
Hokkaido University

A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.

Newswise: Journey Through the Universe Celebrates 20 Years of Exploration on Hawai‘i Island
23-Jan-2024 3:05 PM EST
Journey Through the Universe Celebrates 20 Years of Exploration on Hawai‘i Island
NSF's NOIRLab

Journey Through the Universe — a partnership between the International Gemini Observatory, operated by NSF’s NOIRLab, and the Hawaiʻi Department of Education Hilo-Waiākea Complex Area — celebrates 20 years of cosmic exploration with Hawai‘i students and the community.

Newswise: Journey Through the Universe Celebrates 20 Years of Exploration on Hawai‘i Island
23-Jan-2024 3:05 PM EST
Journey Through the Universe Celebrates 20 Years of Exploration on Hawai‘i Island
NSF's NOIRLab

Journey Through the Universe — a partnership between the International Gemini Observatory, operated by NSF’s NOIRLab, and the Hawaiʻi Department of Education Hilo-Waiākea Complex Area — celebrates 20 years of cosmic exploration with Hawai‘i students and the community.

Newswise: Journey Through the Universe celebra 20 años de exploración en la isla de Hawai‘i
24-Jan-2024 4:30 PM EST
Journey Through the Universe celebra 20 años de exploración en la isla de Hawai‘i
NSF's NOIRLab

Journey Through the Universe: una asociación entre el Observatorio Internacional Gemini, operado por NOIRLab de NSF, y el Departamento de Educación Hilo-Waiākea Complex Area de Hawaiʻi celebra 20 años de exploración cósmica con los estudiantes y la comunidad de Hawai‘i.

Newswise: How Obesity Dismantles Our Mitochondria
25-Jan-2024 8:00 AM EST
How Obesity Dismantles Our Mitochondria
University of California San Diego

UC San Diego researchers found that when mice were fed a high-fat diet, mitochondria within their fat cells broke apart and were less able to burn fat, leading to weight gain.

Newswise: How Obesity Dismantles Our Mitochondria
25-Jan-2024 8:00 AM EST
How Obesity Dismantles Our Mitochondria
University of California San Diego

UC San Diego researchers found that when mice were fed a high-fat diet, mitochondria within their fat cells broke apart and were less able to burn fat, leading to weight gain.

24-Jan-2024 8:00 AM EST
New Research Finds Volume Alone Does Not Predict Quality Outcomes in Pediatric Cardiac Surgery
The Society of Thoracic Surgeons

A study of pediatric heart surgery centers across the United States has demonstrated that, when it comes to successful surgery, it’s not just the size of the program that matters in determining quality outcomes.

24-Jan-2024 8:00 AM EST
Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes
The Society of Thoracic Surgeons

In a study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, researchers examined outcomes for patients undergoing SAVR and those undergoing TAVR from 2013 to 2021 in the state of California.

24-Jan-2024 8:00 AM EST
Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer
The Society of Thoracic Surgeons

In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).

26-Jan-2024 11:55 AM EST
New Research Highlights Superior Long-Term Survival with Multi-Arterial Coronary Artery Bypass Grafting Over Single Arterial Grafting
The Society of Thoracic Surgeons

A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterial grafting (MAG) and single arterial grafting (SAG) in coronary artery bypass grafting (CABG) for multivessel coronary revascularization.

Newswise: Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time
26-Jan-2024 1:05 PM EST
Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time
Roswell Park Comprehensive Cancer Center

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large phase 3 clinical trial reported today at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in San Francisco, California.

Newswise: Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time
26-Jan-2024 1:05 PM EST
Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time
Roswell Park Comprehensive Cancer Center

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large phase 3 clinical trial reported today at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in San Francisco, California.

23-Jan-2024 4:05 PM EST
STS Announces Late-Breaker Research to Be Presented at the 2024 Annual Meeting
The Society of Thoracic Surgeons

The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio.

Newswise: Wake Forest Institute for Regenerative Medicine Awarded $160 Million 10-Year U.S. National Science Foundation Regional Innovation Engines Grant
25-Jan-2024 9:05 AM EST
Wake Forest Institute for Regenerative Medicine Awarded $160 Million 10-Year U.S. National Science Foundation Regional Innovation Engines Grant
Wake Forest Institute for Regenerative Medicine

The Wake Forest Institute for Regenerative Medicine (WFIRM) is the recipient of an inaugural U.S. National Science Foundation (NSF) Engines Program award. The NSF Engines: Piedmont Triad Regenerative Medicine Engine is a regional project that provides an innovation ecosystem to stimulate workforce development, job creation, and economic growth through the development of technologies that benefit the emerging industry.

   
Newswise: Wake Forest Institute for Regenerative Medicine Awarded $160 Million 10-Year U.S. National Science Foundation Regional Innovation Engines Grant
25-Jan-2024 9:05 AM EST
Wake Forest Institute for Regenerative Medicine Awarded $160 Million 10-Year U.S. National Science Foundation Regional Innovation Engines Grant
Wake Forest Institute for Regenerative Medicine

The Wake Forest Institute for Regenerative Medicine (WFIRM) is the recipient of an inaugural U.S. National Science Foundation (NSF) Engines Program award. The NSF Engines: Piedmont Triad Regenerative Medicine Engine is a regional project that provides an innovation ecosystem to stimulate workforce development, job creation, and economic growth through the development of technologies that benefit the emerging industry.

   
Newswise: Cultivated Meat Production Costs Could Fall Significantly with New Cells Created at Tufts University
22-Jan-2024 5:05 PM EST
Cultivated Meat Production Costs Could Fall Significantly with New Cells Created at Tufts University
Tufts University

In an advance for cultivated meat technology, researchers have developed bovine muscle stem cells that produce their own growth factors, eliminating the need to add the expensive ingredient in the growth media.

Newswise: Cultivated Meat Production Costs Could Fall Significantly with New Cells Created at Tufts University
22-Jan-2024 5:05 PM EST
Cultivated Meat Production Costs Could Fall Significantly with New Cells Created at Tufts University
Tufts University

In an advance for cultivated meat technology, researchers have developed bovine muscle stem cells that produce their own growth factors, eliminating the need to add the expensive ingredient in the growth media.

23-Jan-2024 11:05 AM EST
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Mount Sinai Health System

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.

23-Jan-2024 11:05 AM EST
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Mount Sinai Health System

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.

24-Jan-2024 11:15 AM EST
Emergency contraception related ER visits dropped significantly over 14 year period
Michigan Medicine - University of Michigan

Following federal approval for over the counter emergency contraception in 2006, emergency departments across the U.S. saw dramatic decreases in related visits and medical charges, a new study suggests.

24-Jan-2024 11:15 AM EST
Emergency contraception related ER visits dropped significantly over 14 year period
Michigan Medicine - University of Michigan

Following federal approval for over the counter emergency contraception in 2006, emergency departments across the U.S. saw dramatic decreases in related visits and medical charges, a new study suggests.

22-Jan-2024 10:00 PM EST
Signs of Accelerated Aging Found in Brains of Individuals with Alcohol Use Disorder
Research Society on Alcoholism

The brains and blood of people with a history of excessive drinking show cellular evidence of premature aging.

     
22-Jan-2024 10:00 PM EST
Signs of Accelerated Aging Found in Brains of Individuals with Alcohol Use Disorder
Research Society on Alcoholism

The brains and blood of people with a history of excessive drinking show cellular evidence of premature aging.

     
Newswise: Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
24-Jan-2024 4:05 PM EST
Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
University of Maryland School of Medicine

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

22-Jan-2024 11:05 AM EST
Experts call for major shift in international decision-making to tackle ‘devastating’ impact of urban expansion and avoid ‘planetary catastrophe’
University of Bristol

Leading scientists are today calling for an urgent step change in global governance to save the future of worldwide cities and the planet at large.

Not for public release

This news release is embargoed until 25-Jan-2024 2:00 PM EST Released to reporters: 24-Jan-2024 3:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Jan-2024 2:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 25-Jan-2024 2:00 PM EST Released to reporters: 24-Jan-2024 3:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Jan-2024 2:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Query Closed
Reporter's Deadline Passed
23-Jan-2024 11:58 AM EST
Hello, I'm looking for - Rebecca Sohn, Live Science
Newswise Expert Queries

Hello, I'm looking for someone who does research related to or using placental organoids,

   
Newswise: Cervical cancer rates rising in low-income U.S. counties
24-Jan-2024 5:05 PM EST
Cervical cancer rates rising in low-income U.S. counties
University of Texas MD Anderson Cancer Center

Women in low-income areas of the U.S. face a stark rise in cervical cancer incidence and mortality, according to a new study led by researchers from The University of Texas MD Anderson Cancer Center.

Newswise: Cervical cancer rates rising in low-income U.S. counties
24-Jan-2024 5:05 PM EST
Cervical cancer rates rising in low-income U.S. counties
University of Texas MD Anderson Cancer Center

Women in low-income areas of the U.S. face a stark rise in cervical cancer incidence and mortality, according to a new study led by researchers from The University of Texas MD Anderson Cancer Center.

25-Jan-2024 9:00 AM EST
Icahn Mount Sinai School of Medicine Receives Helmsley Charitable Trust Grant for Crohn's Disease Research
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million from The Leona M. and Harry B. Helmsley Charitable Trust to support an innovative research project aimed at understanding the early stages of Crohn’s disease before noticeable symptoms develop.

25-Jan-2024 9:00 AM EST
Icahn Mount Sinai School of Medicine Receives Helmsley Charitable Trust Grant for Crohn's Disease Research
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million from The Leona M. and Harry B. Helmsley Charitable Trust to support an innovative research project aimed at understanding the early stages of Crohn’s disease before noticeable symptoms develop.

22-Jan-2024 9:00 AM EST
Women exposed to toxic metals may experience earlier aging of their ovaries
Endocrine Society

Middle-aged women who are exposed to toxic metals may have fewer eggs in their ovaries as they approach menopause, according to new research published in The Journal of Clinical Endocrinology & Metabolism.

24-Jan-2024 8:05 AM EST
A Study of How Americans Die May Improve Their End of Life
Rutgers University-New Brunswick

Nearly all older U.S. citizens follow one of nine trajectories in their last three years, Rutgers Health researchers say.

24-Jan-2024 8:05 AM EST
A Study of How Americans Die May Improve Their End of Life
Rutgers University-New Brunswick

Nearly all older U.S. citizens follow one of nine trajectories in their last three years, Rutgers Health researchers say.

Query Closed
Reporter's Deadline Passed
23-Jan-2024 8:12 AM EST
Dear Sir/Madam, I trust - Inga de Jong, Senior Journalist
Newswise Expert Queries

Dear Sir/Madam, I trust this email finds you well. I am a senior journalist

19-Jan-2024 3:05 PM EST
Can We Predict When a Migraine Attack Will Occur?
American Academy of Neurology (AAN)

Migraine is often underdiagnosed and untreated, and even when it is treated, it can be difficult to treat early enough as well as find strategies to prevent attacks.

19-Jan-2024 3:05 PM EST
Can We Predict When a Migraine Attack Will Occur?
American Academy of Neurology (AAN)

Migraine is often underdiagnosed and untreated, and even when it is treated, it can be difficult to treat early enough as well as find strategies to prevent attacks.

Newswise: Galápagos penguin is exposed to and may accumulate microplastics at high rate within its food web, modelling suggests
19-Jan-2024 12:05 PM EST
Galápagos penguin is exposed to and may accumulate microplastics at high rate within its food web, modelling suggests
PLOS

Modelling shows how microplastics may bioaccumulate in the Galápagos Islands food web, with Galápagos penguins most affected, according to a study published January 24, 2024 in the open-access journal PLOS ONE.

23-Jan-2024 5:05 PM EST
Exposure to flame retardants linked to premature birth, higher birth weight
UC Davis Health

Exposure to organophosphate ester flame retardants during pregnancy is linked to premature births, according to new research published in Environmental Health Perspectives.



close
7.35391